Zyvox achieves higher clinical success rate than vancomycin in MRSA nosocomial pneumonia study
Links shared publicly online about this topic.
- 785total visits
Zyvox achieves higher clinical success rate than vancomycin in MRSA nosocomial pneumonia study
Results of a new international phase 4 study of patients with nosocomial pneumonia due to proven methicillin-resistant Staphylococcus aureus (MRSA) demonstrated that the antibiotic Zyvox® (linezolid) achieved a statistically significantly higher clinical success rate compared with vancomycin for the primary endpoint. The ZEPHyR (Linezolid in the treatment of subjects with nosocomial pneumonia proven to be due to methicillin-resistant Staphylococcus aureus) study was the largest ever conduct
View full resource at news-medical.net
Tags: MRSA, Pneumonia, Antibiotic, Zyvox, Vancomycin
Most Recently Shared on October 21, 2010 at 1:10 pm By:
Zyvox achieves higher clinical success rate than vancomycin in MRSA nosocomial pneumonia study: Results of a new i... http://bit.ly/9veTO6
Advertisement
